NLRP3 and Parkinson disease: In this study, we revealed that BBR could ameliorate PD-like pathophysiology by enhancing autophagy process and inhibit the activation of NLRP3 inflammasome, which provides a novel neuroprotective mechanism of BBR and to be a potential therapeutic agent for PD.